Tyra Biosciences (TYRA) announced that the U.S. FDA cleared its Investigational New Drug application for TYRA-300 allowing the company to ...
NDAQ:TYRA) Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302) ...
Tyra Biosciences, Inc. (NASDAQ: TYRA) shares decreased in price Friday. The Carlsbad, Calif.-based Tyra, a clinical-stage biotechnology company focused on developing next-generation precision ...
Chicago Sky standout Angel Reese has made headlines once again, this time gracing the cover of Vogue’s Winter 2025 issue, per ...
Fintel reports that on January 7, 2025, UBS initiated coverage of Tyra Biosciences (NasdaqGS:TYRA) with a Buy recommendation.
Check the time stamp on this data. Updated AI-Generated Signals for Tyra Biosciences Inc. (TYRA) available here: TYRA. Type a ...